Eagle Pharmaceuticals Inc (EGRX) Stock Falls -10.46% This Week: Is It a Good Pick?

Eagle Pharmaceuticals Inc (EGRX) stock has fallen -83.75% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives EGRX stock a score of 1 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 1. EGRX's rank also includes a short-term technical score of 2.

EGRX has an Overall Score of 1. Find out what this means to you and get the rest of the rankings on EGRX!

See Full EGRX Report

What's Happening with EGRX Stock Today

Eagle Pharmaceuticals Inc (EGRX) stock is higher by 5.4% while the S&P 500 is higher by 0.51% as of 12:37 PM on Monday, Dec 18. EGRX is higher by $0.25 from the previous closing price of $4.63 on volume of 255,162 shares. Over the past year the S&P 500 is higher by 24.25% while EGRX has fallen -83.75%. EGRX earned $0.91 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 5.28. Click Here to get the full Stock Report for Eagle Pharmaceuticals Inc stock.